A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

NCT07168200 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cervical Cancer

Interventions

DRUG: SHR-1316 Injection
DRUG: Cisplatin Injection
DRUG: Carboplatin Injection
DRUG: Paclitaxel Injection
DRUG: SHR-1316 Placebo Injection

Sponsor

Shanghai Shengdi Pharmaceutical Co., Ltd